Baker Bros. Advisors LP Rhythm Pharmaceuticals, Inc. Transaction History

Baker Bros. Advisors LP

$9.34 Billion
Q3 2024

A detailed history of Baker Bros. Advisors LP transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 6,398,366 shares of RYTM stock, worth $357 Million. This represents 3.59% of its overall portfolio holdings.

Number of Shares

6,398,366

Previous 6,398,365 -0.0%

Holding current value

$357 Million

Previous $263 Million 27.59%

% of portfolio

3.59%

Previous 3.49%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.81 - $55.0 $40 - $55	1 Added 0.0%	6,398,366 $335 Million
Q4 2023 Feb 14, 2024	SELL	$21.39 - $49.64 $6.5 Million - $15.1 Million	-303,984 Reduced 4.54%	6,398,365 $294 Million
Q3 2023 Nov 14, 2023	BUY	$15.81 - $27.8 $3.23 Million - $5.67 Million	204,082 Added 3.14%	6,702,349 $154 Million
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $2.42 Million - $4.92 Million	143,659 Added 2.26%	6,498,267 $116 Million
Q4 2022 Feb 14, 2023	BUY	$22.21 - $30.25 $6.48 Million - $8.83 Million	291,906 Added 4.81%	6,354,608 $185 Million
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $8.33 Million - $59.8 Million	1,937,640 Added 46.97%	6,062,702 $149 Million
Q1 2022 May 16, 2022	BUY	$6.13 - $12.24 $1.6 Million - $3.2 Million	261,823 Added 6.78%	4,125,062 $47.5 Million
Q2 2021 Aug 16, 2021	BUY	$18.52 - $22.55 $7.1 Million - $8.64 Million	383,366 Added 11.02%	3,863,239 $75.6 Million
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $23.6 Million - $46 Million	1,165,000 Added 50.33%	3,479,873 $74 Million
Q4 2020 Feb 16, 2021	SELL	$21.17 - $32.61 $3.31 Million - $5.1 Million	-156,282 Reduced 6.32%	2,314,873 $68.8 Million
Q3 2020 Nov 16, 2020	SELL	$18.13 - $30.61 $4.15 Million - $7.01 Million	-228,900 Reduced 8.48%	2,471,155 $53.6 Million
Q2 2020 Aug 14, 2020	SELL	$14.41 - $25.35 $117,369 - $206,475	-8,145 Reduced 0.3%	2,700,055 $60.2 Million
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $11.2 Million - $23.2 Million	659,180 Added 32.17%	2,708,200 $84.7 Million
Q4 2017 Feb 14, 2018	BUY	$22.0 - $30.51 $45.1 Million - $62.5 Million	2,049,020	2,049,020 $59.5 Million

Others Institutions Holding RYTM

# of Institutions

191

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.11B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Account

Baker Bros. Advisors LP Rhythm Pharmaceuticals, Inc. Transaction History